Biotech Values

[DewDiligence]

Biopharmaceutical Patent Expirations

With the proviso that biopharmaceuticals (other than insulin and hGH, which are regulated as small molecules) are not listed in the FDA’s Orange Book and hence it’s difficult to be sure about which patents apply to a given drug, the recent biogenerics report by Cowen has some tables on the U.S. patent expirations of selected biopharmaceuticals.

I will email a copy of the report late this evening to everyone who has signed up to receive email distributions on this board.

If you have not signed up to receive email distributions and would like to sign up, please see #msg-13693059.

Dew